Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma, Synovial 9Sarcoma 9Osteosarcoma 8Neoplasms 7Melanoma 7Liposarcoma, Myxoid 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Myelodysplastic Syndromes 6Leukemia, Myeloid, Acute 6Dendritic Cell Sarcoma, Interdigitating 6Sarcoma, Ewing 5Ovarian Neoplasms 5Multiple Myeloma 5Lymphoma, Mantle-Cell 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Burkitt Lymphoma 5Rhabdomyosarcoma 4Lymphoma, Follicular 4Leukemia, Prolymphocytic 4Triple Negative Breast Neoplasms 3Lymphoma, T-Cell 3Leukemia 3Esophageal Neoplasms 3Wilms Tumor 2Urinary Bladder Neoplasms 2Stomach Neoplasms 2

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gaucher Disease × fludarabine × Sarcoma × Clear all
NCT03721068 2026-03-27

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
18 enrolled
CNSSarcoma

Gaucher Disease, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡